Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors

Paul van der Leest, Birgitta Hiddinga, Anneke Miedema, Maria L Aguirre Azpurua, Naomi Rifaela, Arja Ter Elst, Wim Timens, Harry J M Groen, Léon C van Kempen, T Jeroen N Hiltermann, Ed Schuuring^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

21 Citations (Scopus)

218 Downloads (Pure)

21 Citations
1 Erratum

1 results

2022
Erratum to: Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors.
van der Leest, P., Hiddinga, B., Miedema, A., Azpurua, A. M. L., Rifaela, N., ter Elst, A., Timens, W., Groen, H. J. M., van Kempen, L. C. & Hiltermann, T. J. N., Jan-2022, In: Molecular oncology. 16, 1, p. 310-310 1 p.
Research output: Contribution to journal › Erratum

Open Access
File
72 Downloads (Pure)